trial
as of 2026-07-01RCT of Methotrexate Added to Treatment As Usual in Schizophrenia
NCTId NCT02074319
at a glance
Phase 1 · Completed
Enrollment 92 (actual)
Sponsored by Pakistan Institute of Living and Learning
Primary completion 2015-07
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 1
Status
Completed
Enrollment
92 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2013-12
Primary completion
2015-07
Eligibility
ALL · 18 Years · 35 Years
Interventions & indications
Sponsors
Pakistan Institute of Living and LearningLead Sponsor
Abbasi Shaheed HospitalCollaborator
Dow University of Health SciencesCollaborator
Karwan e Hayat, Karachi, PakistanCollaborator
Investigators
1
Prof Imran B Chaudhry, MDPrincipal Investigator
Sites
4 total
Karachi, PakistanKarachi, PakistanKarachi, PakistanKarachi, Pakistan
Facts & assertions
4 sourced
Enrollment
92
Phase
PHASE1
Primary Completion Date
2015-07
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
collaborator
company
indication
investigator